Literature DB >> 21921046

A zebrafish model of dyskeratosis congenita reveals hematopoietic stem cell formation failure resulting from ribosomal protein-mediated p53 stabilization.

Tamara C Pereboom1, Linda J van Weele, Albert Bondt, Alyson W MacInnes.   

Abstract

Dyskeratosis congenita (DC) is a bone marrow failure disorder characterized by shortened telomeres, defective stem cell maintenance, and highly heterogeneous phenotypes affecting predominantly tissues that require high rates of turnover. Here we present a mutant zebrafish line with decreased expression of nop10, one of the known H/ACA RNP complex genes with mutations linked to DC. We demonstrate that this nop10 loss results in 18S rRNA processing defects and collapse of the small ribosomal subunit, coupled to stabilization of the p53 tumor suppressor protein through small ribosomal proteins binding to Mdm2. These mutants also display a hematopoietic stem cell deficiency that is reversible on loss of p53 function. However, we detect no changes in telomere length in nop10 mutants. Our data support a model of DC whereupon in early development mutations involved in the H/ACA complex contribute to bone marrow failure through p53 deregulation and loss of initial stem cell numbers while their role in telomere maintenance does not contribute to DC until later in life.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921046     DOI: 10.1182/blood-2011-04-351460

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Pseudouridylation defect due to DKC1 and NOP10 mutations causes nephrotic syndrome with cataracts, hearing impairment, and enterocolitis.

Authors:  Eszter Balogh; Jennifer C Chandler; Máté Varga; Mona Tahoun; Dóra K Menyhárd; Gusztáv Schay; Tomas Goncalves; Renáta Hamar; Regina Légrádi; Ákos Szekeres; Olivier Gribouval; Robert Kleta; Horia Stanescu; Detlef Bockenhauer; Andrea Kerti; Hywel Williams; Veronica Kinsler; Wei-Li Di; David Curtis; Maria Kolatsi-Joannou; Hafsa Hammid; Anna Szőcs; Kristóf Perczel; Erika Maka; Gergely Toldi; Florentina Sava; Christelle Arrondel; Magdolna Kardos; Attila Fintha; Ahmed Hossain; Felipe D'Arco; Mario Kaliakatsos; Jutta Koeglmeier; William Mifsud; Mariya Moosajee; Ana Faro; Eszter Jávorszky; Gábor Rudas; Marwa H Saied; Salah Marzouk; Kata Kelen; Judit Götze; George Reusz; Tivadar Tulassay; François Dragon; Géraldine Mollet; Susanne Motameny; Holger Thiele; Guillaume Dorval; Peter Nürnberg; András Perczel; Attila J Szabó; David A Long; Kazunori Tomita; Corinne Antignac; Aoife M Waters; Kálmán Tory
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-17       Impact factor: 11.205

2.  Ribosome biogenesis dysfunction leads to p53-mediated apoptosis and goblet cell differentiation of mouse intestinal stem/progenitor cells.

Authors:  A Stedman; S Beck-Cormier; M Le Bouteiller; A Raveux; S Vandormael-Pournin; S Coqueran; V Lejour; L Jarzebowski; F Toledo; S Robine; M Cohen-Tannoudji
Journal:  Cell Death Differ       Date:  2015-06-12       Impact factor: 15.828

3.  Selenoprotein H is an essential regulator of redox homeostasis that cooperates with p53 in development and tumorigenesis.

Authors:  Andrew G Cox; Allison Tsomides; Andrew J Kim; Diane Saunders; Katie L Hwang; Kimberley J Evason; Jerry Heidel; Kristin K Brown; Min Yuan; Evan C Lien; Byung Cheon Lee; Sahar Nissim; Bryan Dickinson; Sagar Chhangawala; Christopher J Chang; John M Asara; Yariv Houvras; Vadim N Gladyshev; Wolfram Goessling
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-01       Impact factor: 11.205

4.  Distinct PKC-mediated posttranscriptional events set cytokine production kinetics in CD8+ T cells.

Authors:  Fiamma Salerno; Nahuel A Paolini; Regina Stark; Marieke von Lindern; Monika C Wolkers
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-23       Impact factor: 11.205

5.  Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita.

Authors:  Hemanth Tummala; Amanda Walne; Laura Collopy; Shirleny Cardoso; Josu de la Fuente; Sarah Lawson; James Powell; Nicola Cooper; Alison Foster; Shehla Mohammed; Vincent Plagnol; Thomas Vulliamy; Inderjeet Dokal
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

6.  FGFR2 mutations in bent bone dysplasia syndrome activate nucleolar stress and perturb cell fate determination.

Authors:  Cynthia L Neben; Creighton T Tuzon; Xiaojing Mao; Fides D Lay; Amy E Merrill
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

7.  Guilty as CHARGED: p53's expanding role in disease.

Authors:  Jeanine L Van Nostrand; Laura D Attardi
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 8.  Probing the mechanisms underlying human diseases in making ribosomes.

Authors:  Katherine I Farley; Susan J Baserga
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

Review 9.  New prospects for targeting telomerase beyond the telomere.

Authors:  Greg M Arndt; Karen L MacKenzie
Journal:  Nat Rev Cancer       Date:  2016-06-24       Impact factor: 60.716

10.  p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage.

Authors:  J Carrillo; A González; C Manguán-García; L Pintado-Berninches; R Perona
Journal:  Clin Transl Oncol       Date:  2013-09-25       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.